Clinical Trial Management Systems (CTMS) are vital to modern clinical research, offering essential tools to manage and track all operational aspects of the trial process. Clinical trials’ increasing complexity, the growing data volume, and the need for enhanced collaboration have transformed CTMS platforms from basic on-premise, siloed data management systems to cloud-based, integrated systems.

Initially focused on addressing manual, paper-based limitations, early CTMS lacked integration capabilities. Over time, technology advances, regulatory demands, and growing trial complexity led to the emergence of modern CTMS platforms that offer enhanced features such as integration with electronic health records, remote monitoring, and real-time actionable insights. CTMS platform providers continue to invest in AI/ML, automation, and advanced analytics to enable more efficient clinical trials. By providing real-time insights, automating routine processes, and allowing better data management, modern CTMS platforms ensure trial operations are streamlined and more effective, leading to more informed decision-making and faster trial execution.

• Life Sciences Clinical Trial Management System (CTMS) Products PEAK Matrix® Assessment 2024

  

  What is in this PEAK Matrix® Report

  In this report, we assess 13 CTMS providers’ capabilities. The providers are mapped on the Everest Group PEAK Matrix^®, a composite index of a range of distinct metrics related to a provider’s capability and market impact.

  Scope:

  • Industry: life sciences
  • Geography: global

  Contents:

  In this report, we assess:

  • The CTMS product provider landscape
  • CTMS product providers on several capabilities and market success-related dimensions

  READ ON

What is the PEAK Matrix®?

The PEAK Matrix® provides an objective, data-driven assessment of service and technology providers based on their overall capability and market impact across different global services markets, classifying them into three categories: Leaders, Major Contenders, and Aspirants.

LEARN MORE ABOUT Top Service Providers

WATCH THE LINKEDIN LIVE ON-DEMAND

Pharma enterprises are facing multiple challenges, including loss of exclusivity and declining R&D productivity, pushing them to rethink their clinical operations strategies. At the same time, technology advancements are transforming the clinical operations landscape, leading providers to innovate rapidly.

Watch this LinkedIn Live session to explore the major challenges pharma companies encountered in 2024 and how these are reshaping clinical operations. We’ll also dive into how evolving technology is driving transformation and what this means for selecting the right providers – from product and CROs to IT/BP service providers.

Participants gained valuable insights into how pharma enterprises should evolve their sourcing strategies and how providers can prepare for the growth opportunities and market dynamics of 2025.

During this collaborative LinkedIn Live session, we discussed:

What challenges do pharma enterprises face, and how do these impact clinical operations?
What are the evolving technology trends impacting clinical operations?
How are pharma enterprises evolving their sourcing criteria for this space?
What is Everest Group’s take on the market sentiment for clinical operations in 2025?

Clinical Trial

VIEW THE FULL REPORT

View the event on LinkedIn, which was delivered live on Wednesday, May 8, 2024.

Watch this LinkedIn Live session with Everest Group’s Kriti Gupta, Practice Director, Katrina Menzigian, Vice President, and Nisarg Shah, Practice Director, for an example-focused discussion on Everest Group’s research into technology provider and platform markets.

Using two vertical segments, Healthcare and Life Sciences , and Banking, Financial Services, and Insurance , our experts explored how our research-based approach helps identify technology product market opportunities and develop effective go-to-market strategies and positioning.

What questions did this LinkedIn Live answer for the participants?

1. What technologies and platform markets does Everest Group cover?
2. What is unique about Everest Group’s approach to its coverage of technology provider and platform markets?
3. What kinds of business challenges and objectives are the target of Everest Group’s technology product research?

WATCH THE LINKEDIN LIVE ON-DEMAND

In the rapidly advancing field of clinical technology, pharma enterprises are faced with challenges such as fragmented data, compounded by interoperability issues and inefficiencies. There is a growing need for real-time insights and a unified data platform to enhance clinical decision-making, interoperability, and operational efficiency.

Watch this interactive LinkedIn Live session to explore how an end-to-end platform approach to clinical data and analytics can enable seamless data integration, improve data quality, accelerate trial timelines, and improve patient outcomes. Additionally, discover the evolving areas in clinical data and analytics and get a view of the outlook for this segment.

During this event, we dived into questions such as:

• What are the existing pharma challenges around clinical data and analytics?
• What are the key demand trends and expectations from clinical data and analytics platform providers?
• What does the provider ecosystem look like in this segment?
• What are some of the emerging or futuristic trends within this segment?

Decentralized Clinical Trials (DCTs) are transforming the landscape of clinical research by harnessing digital technologies to facilitate remote patient participation. This patient-centric approach not only benefits participants but also ensures more inclusive and robust study results while reducing the workload for investigators. In the post-pandemic climate, a hybrid model is emerging that seamlessly integrates technology advances with traditional site workflows, creating a new era of clinical trials that harnesses the strengths of both. In a funding-constrained environment, DCT platform providers are looking to strike a balance between client satisfaction and cost reduction. They are focusing on delivering comprehensive solutions that include real-world evidence, integration with sensors and wearables, and tools dedicated to enhancing patient engagement and retention throughout the trial process.

• Decentralized Clinical Trial Platforms PEAK Matrix® Assessment 2023

  

  What is in this PEAK Matrix® Report

  In this report, we assess the capabilities of 22 platform providers specific to the decentralized clinical trial landscape. These platform providers are mapped on the Everest Group PEAK Matrix®, a composite index of a range of distinct metrics related to a provider’s capability and market impact.

  Content:

  In this report, we:

  • Examine the provider landscape for DCTs
  • Assess DCT platform providers on several capabilities and market success-related dimensions

  Scope:

  • Industry: Life sciences clinical development technology
  • Geography: global

  READ ON

What is the PEAK Matrix®?

The PEAK Matrix® provides an objective, data-driven assessment of service and technology providers based on their overall capability and market impact across different global services markets, classifying them into three categories: Leaders, Major Contenders, and Aspirants.

LEARN MORE ABOUT Top Service Providers

Clinical Development Platforms

VIEW THE FULL REPORT

Clinical Value Chain

VIEW THE FULL REPORT

In the past, the manufacturing industry primarily focused on designing standardized manufacturing procedures and managing labor and mechanical systems. However, the advent of Industry 4.0 has led to the widespread adoption of technology across various sectors, unlocking numerous benefits. Nevertheless, the life sciences industry has been slow in embracing technology to modernize its manufacturing setups. The pandemic, regulatory frameworks, and the drive for operational excellence are now propelling the adoption of smart manufacturing services.

Life sciences enterprises are striving to unlock benefits such as cost optimization, increased productivity, visibility, and efficiency through investments in vital use cases such as digital twins and predictive maintenance. They are also exploring high-growth opportunities such as sustainable manufacturing, batch-to-continuous manufacturing, and personalized medicine production. As the industry receives investments in smart manufacturing, providers are assuming the role of end-to-end digital transformation partners by collaboratively developing solutions to assist enterprises in their digital journeys.

• Life Sciences Smart Manufacturing Services PEAK Matrix® Assessment 2023

  

  What is in this PEAK Matrix® Report

  In this report, we assess 16 life sciences smart manufacturing service providers featured on Everest Group’s Life Sciences Smart Manufacturing Services PEAK Matrix® 2023. Each provider profile offers a comprehensive picture of its service focus, key IP/solutions, domain investments, and case studies. The study will enable buyers to make the right sourcing decisions based on their requirements, while providers will be able to benchmark themselves against their competitors.

  Content:

  • The provider landscape for life sciences smart manufacturing services
  • The providers’ assessment on several capability and market success-related dimensions

  Scope:

  • Industry: life sciences
  • Geography: global
  • The assessment is based on Everest Group’s annual RFI process for the calendar year 2023, interactions with leading life sciences service providers, client reference checks, and an ongoing analysis of the IT services market

   

  READ ON

What is the PEAK Matrix®?

The PEAK Matrix® provides an objective, data-driven assessment of service and technology providers based on their overall capability and market impact across different global services markets, classifying them into three categories: Leaders, Major Contenders, and Aspirants.

LEARN MORE ABOUT Top Service Providers

Due to decentralized and hybrid designs, the growing clinical trial complexity generates vast data volumes from diverse sources and creates significant data management challenges. In response, sponsors are increasingly employing unified clinical data and analytics (D&A) platforms to centralize and standardize clinical data to gain actionable insights, offering real-time monitoring, predictive analytics, and risk management. These platforms transform disparate datasets into cohesive, structured formats, allowing stakeholders to detect outliers, predict adverse events, and generate on-demand dashboards and reports.

D&A platforms offer centralized repositories, Risk-Based Quality Management (RBQM), and seamless integration with Electronic Health Records (EHRs), wearables, and medical devices. These features improve data access and interoperability, contributing to more informed decision-making and enhanced quality and risk oversight. Clinical D&A platform providers are incorporating cutting-edge AI and generative AI capabilities to automate repetitive tasks, generate insights, and strengthen quality and risk management to address sponsor needs.

• Life Sciences Clinical Data and Analytics (D&A) Platforms PEAK Matrix® Assessment 2024

  

  What is in this PEAK Matrix® Report

  In this report, we analyze 18 clinical D&A platform providers featured on the Everest Group’s PEAK Matrix® based on their capabilities, offerings, and market impact. The report will empower buyers to choose the right provider for their sourcing considerations and enable providers to benchmark themselves against their competition.

  Content:

  In this report, we:

  • Examine the provider landscape for clinical D&A platforms
  • Assess clinical D&A platform providers on capabilities and market success-related dimensions
  • Position the providers on Everest Group’s PEAK Matrix® framework as Leaders, Major Contenders, and Aspirants
  • Compare providers’ key strengths and limitations

  Scope:

  • Industry: life sciences
  • Geography: global

  READ ON

• Life Sciences Clinical Data and Analytics (D&A) Platforms PEAK Matrix® Assessment 2023

  

  What is in this PEAK Matrix® Report

  In this report, we assess 14 clinical Data and Analytics (D&A) platform providers. The providers are positioned on Everest Group’s PEAK Matrix®, a composite index of a range of distinct metrics related to the providers’ capabilities and market impact. The study will enable buyers to choose the best-fit provider based on their sourcing considerations, while providers will be able to benchmark their performance against each other.

  Content:

  In this report, we:

  • Examine the provider landscape for clinical D&A platforms
  • Assess clinical D&A platform providers on several capabilities and market success-related dimensions

  Scope:

  • Industry: life sciences
  • Geography: global

  READ ON

   

What is the PEAK Matrix®?

The PEAK Matrix® provides an objective, data-driven assessment of service and technology providers based on their overall capability and market impact across different global services markets, classifying them into three categories: Leaders, Major Contenders, and Aspirants.

LEARN MORE ABOUT Top Service Providers